CLINICAL_TRIALS
trial_result
· 2015-12-17
Clinical Trial Update: Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery [Phase 2]
Summary
Phase 2 study evaluating gemcitabine plus oxaliplatin (GEMOX) in patients with resectable pancreatic cancer. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-12-17